The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Treating HIV-Associated Lymphoma

Joseph Alvarnas, MD
Published Online: 11:44 PM, Sun December 7, 2014
Joseph Alvarnas, MD, Director of Medical Quality, associate clinical professor, City of Hope, discusses the treatment of HIV-associated lymphoma.

Clinical Pearls

  • The most appropriate way to treat patients with HIV and lymphoma has been a quandary for years.
  • This study looked at autologous hematopoietic stem cell transplantation for the treatment of patients with chemotherapy-sensitive, relapsed/refractory HIV-associated lymphoma.
  • Estimated probability of one-year OS was 86.6%.

<<< Go back to the ASH conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.